COMMUNIQUÉS West-GlobeNewswire

Virbac: Availability of the first half-yearly financial report as of June 30, 2017

11/09/2017 - 17:45

Virbac Availability of the first half-yearly financial report as of June 30, 2017 Public release - September 11 th , 2017 Virbac announced today that the 2017 half-yearly financial report is now available and has been [...]

Biocartis Group NV: Results of the extraordinary shareholders' meeting held on 11 September 2017

11/09/2017 - 17:40

PRESS RELEASE: REGULATED INFORMATION 11 September 2017, 17:40 CEST Results of the extraordinary shareholders' meeting held on 11 September 2017 Mechelen, Belgium, 11 September 2017 - Biocartis Group NV (the 'Company' or [...]

Weifa ASA: Karo Pharma commences voluntary cash offer to acquire the entire issued share capital of Weifa

11/09/2017 - 15:30

Weifa ASA ("Weifa"; OSE: WEIFA) today announced that Karo Pharma AB (publ) ("Karo Pharma"), has commenced the voluntary cash offer (the "Offer") to acquire the entire issued share capital of Weifa for NOK 35 per share. [...]

Minerva Neurosciences Names Dr. Jay Saoud as Senior Vice President, Head of Research and Development

11/09/2017 - 14:30

WALTHAM, Mass., Sept. 11, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]

EDAP Announces Filing of New 510(k) Application for Focal One® Device

11/09/2017 - 13:30

510(k) Includes New Clinical Data to Support EDAP's File LYON, France, September 11, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that the Company submitted a new 510(k [...]

Genedrive® HCV ID Kit received CE-IVD Certification

11/09/2017 - 13:30

11 September 2017 genedrive plc ("genedrive" or the "Company") Genedrive® HCV ID Kit received CE-IVD Certification Hepatitis C assay provides decentralised molecular testing to support the identification of patients [...]

Apricus Biosciences Announces $3.7 Million Private Placement Priced At-The-Market

11/09/2017 - 13:00

SAN DIEGO, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has entered into [...]

ObsEva SA Announces Presentation Related to its PGF2alpha Receptor Antagonist at ACCP 2017 Annual Meeting

11/09/2017 - 13:00

Phase 1 clinical trial results in healthy subjects support cardiac safety of OBE022 Geneva, Switzerland and Boston, MA - 11 September, 2017 - ObsEva SA (NASDAQ: OBSV), a Swiss biopharmaceutical company focused on the [...]

Shire's Investigational Subcutaneous C1 esterase inhibitor (C1 INH [Human]) Liquid for Injection (SHP616) Significantly Reduces HAE Monthly Attack Rate Versus Placebo in a Phase 3 Pivotal Trial

11/09/2017 - 13:00

Shire's Investigational Subcutaneous C1 esterase inhibitor (C1 INH [Human]) Liquid for Injection (SHP616) Significantly Reduces Hereditary Angioedema Monthly Attack Rate Versus Placebo in a Phase 3 Pivotal Trial Median [...]

Summit Therapeutics Awarded BARDA Contract Worth Up To $62M To Support Development of Ridinilazole for CDI

11/09/2017 - 13:00

Summit Therapeutics plc ('Summit Therapeutics', Summit', or the 'Company') SUMMIT AWARDED BARDA CONTRACT WORTH UP TO $62 MILLION TO SUPPORT THE DEVELOPMENT OF RIDINILAZOLE FOR THE TREATMENT OF C. DIFFICILE INFECTION [...]

Shire plc : Elections for the interim dividend in respect of the six months to June 30, 2017

11/09/2017 - 13:00

Elections for the interim dividend in respect of the six months to June 30, 2017 September 11, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announced on August 3, 2017, an interim dividend of 5.09 US cents [...]

Medtronic Announces Voluntary Recall of Diabetes Infusion Sets

11/09/2017 - 12:45

DUBLIN - September 11, 2017 - Medtronic plc (NYSE:MDT) announced today that it has started to inform patients worldwide of a voluntary recall of specific lots of infusion sets used with all models of Medtronic insulin [...]

Novo Nordisk A/S - Share repurchase programme

11/09/2017 - 12:26

Bagsværd, Denmark, 11 September 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

Symphogen A/S: Symphogen presents detailed results for randomized Phase 2 study with Sym004 in refractory metastatic colorectal cancer at ESMO 2017 Congress

11/09/2017 - 09:45

Symphogen presents detailed results for randomized Phase 2 study with Sym004 in refractory metastatic colorectal cancer at ESMO 2017 Congress Data show clinically meaningful improvement in overall survival in a [...]

Virbac : Déclaration d'actions et de droits de vote au 31 Août 2017

11/09/2017 - 09:29

DECLARATION D'ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d'actions composant le capital (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) [...]

Virbac : Declaration of the number of shares and voting rights as of August 2017, 31.

11/09/2017 - 09:29

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]

Virbac : Déclaration d'actions et de droits de vote au 31 Juillet 2017

11/09/2017 - 09:20

DECLARATION D'ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d'actions composant le capital (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) [...]

Virbac : Declaration of the number of shares and voting rights as of July 2017, 31.

11/09/2017 - 09:20

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]

Principal Investigator Dr. James Gulley to Provide Presentation Entitled "Therapeutic Vaccines in Prostate Cancer" at the ESMO 2017 Congress

11/09/2017 - 09:15

MADRID, September 11, 2017 - This morning at the European Society for Medical Oncology (ESMO) 2017 Congress, Dr. James Gulley, Chief, Genitourinary Malignancies Branch, Senior Investigator, Head, Immunotherapy Section, [...]